On Monday, Altimmune Inc (NASDAQ: ALT) was 7.51% up from the session before settling in for the closing price of $5.59. A 52-week range for ALT has been $3.55 – $11.16.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 104.92% over the last five years. When this article was written, the company’s average yearly earnings per share was at -5.41%. With a float of $76.21 million, this company’s outstanding shares have now reached $77.01 million.
The firm has a total of 59 workers. Let’s measure their productivity. In terms of profitability, gross margin is -905.0%, operating margin of -515860.0%, and the pretax margin is -475295.0%.
Altimmune Inc (ALT) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Altimmune Inc stocks. The insider ownership of Altimmune Inc is 1.04%, while institutional ownership is 53.09%. The most recent insider transaction that took place on Mar 17 ’25, was worth 5,784. In this transaction Director of this company bought 1,000 shares at a rate of $5.78, taking the stock ownership to the 1,000 shares. Before that another transaction happened on Mar 13 ’25, when Company’s Chief Financial Officer bought 10,000 for $5.20, making the entire transaction worth $51,996. This insider now owns 10,000 shares in total.
Altimmune Inc (ALT) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -5.41% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 0.77% during the next five years compared to 3.48% growth over the previous five years of trading.
Altimmune Inc (NASDAQ: ALT) Trading Performance Indicators
You can see what Altimmune Inc (ALT) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 13.10. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 23141.51.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.34, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -1.62 in one year’s time.
Technical Analysis of Altimmune Inc (ALT)
Analysing the last 5-days average volume posted by the [Altimmune Inc, ALT], we can find that recorded value of 2.68 million was better than the volume posted last year of 2.45 million. As of the previous 9 days, the stock’s Stochastic %D was 77.01%. Additionally, its Average True Range was 0.42.
During the past 100 days, Altimmune Inc’s (ALT) raw stochastic average was set at 40.70%, which indicates a significant decrease from 95.20% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 83.07% in the past 14 days, which was higher than the 73.79% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.20, while its 200-day Moving Average is $6.62. Now, the first resistance to watch is $6.12. This is followed by the second major resistance level at $6.22. The third major resistance level sits at $6.38. If the price goes on to break the first support level at $5.85, it is likely to go to the next support level at $5.69. Now, if the price goes above the second support level, the third support stands at $5.59.
Altimmune Inc (NASDAQ: ALT) Key Stats
There are 77,014K outstanding shares of the company, which has a market capitalization of 462.83 million. As of now, sales total 20 K while income totals -95,060 K. Its latest quarter income was 10 K while its last quarter net income were -23,180 K.
